UE-Mexico Dialogues – Drug Policy

Drug policy was the fifth topic of the Seminar. During said workshop, experts from Mexico and Europe established the necessity of determining drug prices based on the added clinical value, as well as to homogenize the drug inclusion criteria, insure the participation of public and private parties, and share information. Finally, an important proposal was to create a generic coherent policy to reduce costs by replacing drugs with equivalent but less expensive products, this can be achieved by promoting confidence in generics, through generic prescription and reference price.